50
Informaciones
Psiquiátricas
2015 - n.º 220
7. Schulze J, van den Bussche H, Glaes-
ke G, Kaduszkiewicz H, Wiese B, Hoff-
mann F. Impact of safety warnings on
antipsychotic prescriptions in dementia:
nothing has changed but the years and
the substances. Eur Neuropsychophar-
macol. 2013 Sep;23(9):1034-42. doi:
10.1016/j.euroneuro.2013.02.001.
Epub 2013 Mar 15.
8. Azermai M, Vander Stichele RR, Van Bor-
tel LM, Elseviers MM. Barriers to anti-
psychotic discontinuation in nursing
homes: an exploratory study. Aging
Ment Health. 2014;18(3):346-53. doi:
10.1080/13607863.2013.832732. Epub
2013 Sep 9.
9. Angora-Cañego R, Esquinas-Requena JL,
Agüera-Ortiz LF. Guía de selección de
psicofármacos en el anciano con pato-
logía médica concomitante. Psicogeria-
tría. 2012;4(1):1-19.
10. Hampton LM, Daubresse M, Chang HY,
Alexander GC, Budnitz DS. Emergency
department visits by adults for psy-
chiatric medication adverse events.
JAMA Psychiatry. 2014 Sep; 71(9):
1006-14. doi: 10.1001/jamapsychia-
try.2014.436.
11. Schneider LS, Tariot PN, Dagerman KS,
Davis SM, Hsiao JK, Ismail MS, et al;
CATIE-AD Study Group. Effectiveness of
atypical antipsychotic drugs in patients
with Alzheimer’s disease. N Engl J Med.
2006 Oct 12;355(15):1525-38.
12. Schneider LS, Dagerman K, Insel PS.
Efficacy and adverse effects of atypi-
cal antipsychotics for dementia: meta-
analysis of randomized, placebo-contro-
lled trials. Am J Geriatr Psychiatry. 2006
Mar;14(3):191-210.
13. Akın S, Bahat G, Tufan F, Saka B, Oztop
N, Erten N, et al. Olanzapine as a cause
of peripheric edema in an elderly man.
Aging Clin Exp Res. 2013 Apr;25(1):115-
7. doi: 10.1007/s40520-013-0002-4.
Epub 2013 Mar 27.
14. Klein-Schwartz W, Schwartz EK, Ander-
son BD. Evaluation of quetiapine abuse
and misuse reported to poison centers.
J Addict Med. 2014 May-Jun;8(3):195-8.
doi: 10.1097/ADM.0000000000000020.
15. Huybrechts KF, Gerhard T, Crystal S, Olf-
son M, Avorn J, Levin R, et al. Differen-
tial risk of death in older residents in
nursing homes prescribed specific antip-
sychotic drugs: population based cohort
study. BMJ. 2012 Feb 23;344:e977. doi:
10.1136/bmj.e977.
16. Yam FK, Jackson EA, Kwan BK. Syndrome
of inappropriate antidiuretic hormone
associated with aripiprazole. Am J Health
Syst Pharm. 2013 Dec 1;70(23):2110-4.
doi: 10.2146/ajhp130142.
17. Osorio RS, Agüera-Ortiz L, Hurtado de
Mendoza A, Ramos I, Palomo T. Treatment
of tardive dyskinesia with aripiprazole.
Neurotox Res. 2010 May;17(4):432-4.
18. Mazzucco S, Cipriani A, Barbui C, Monaco
S. Antipsychotic drugs and cerebrovas-
cular events in elderly patients with de-
mentia: a systematic review. Mini Rev Med
Chem. 2008 Jul;8(8):776-83. Review.
19. Streim JE, Porsteinsson AP, Breder CD,
Swanink R, Marcus R, McQuade R, et al.
López Álvarez J / Agüera-Ortiz LF
